Mar 29, 2021|

JD Health FY 2020: Accelerating Digitalization Through Technology


by Hui Zhang

Lijun Xin, CEO of JD Health stressed the importance of technology in the process of digitalizing the healthcare industry, in a letter accompanying the release of JD Health’s 2020 financial results on Mar. 29.

These are the first annual results the company have released since its listing on the Hong Kong Stock Exchange (6618.HK) on Dec. 8, 2020.

JD Health strives to promote the development of the technology-driven digitalized and intelligent healthcare industry by partnering with public hospitals at all levels to embrace “Internet + Healthcare”, piloting Health City projects, as well as developing AI-based applications of medication services, according to Xin.

JD Health has cooperated with a number of top-tier hospitals in China to build Internet hospitals, developing patient-centered, online and offline integrated smart solutions throughout the entire medical process and helping improve patients’ medical experiences.

For example, JD Health cooperated with Tianjin Nankai Hospital to build the Nankai JD Internet Hospital by providing Tianjin residents with consultation, health management advisory and services for follow-up visits. Meanwhile, with the support of Tianjin’s regional basic medical insurance policy, JD Health is able to connect to basic medical insurance reimbursement services for follow-up consultations and medications.

In terms of launching “Health City” projects, JD Health cooperated with the Health Commission of Hubei province, jointly promoting rehabilitation and psychological consultation projects for patients recovered from COVID-19 . Additionally, JD Health is helping the city of Beihai to digitalize its regional resident health system and enhance its medical services by expanding and improving the city’s health information platform and developing “Internet + Healthcare” application systems.

JD Heath has also applied AI technology to medication services for enhancing medication safety. Since July 2019, JD Health has been working with the pharmacist team of the Third Hospital of Peking University to develop an AI-enabled pharmaceutical knowledge graph. Meanwhile, JD Health has also built a regional AI-based prescription vetting center with the Beijing Haidian District Health Commission. The center is dedicated to building a knowledge base for medical supply and prescription vetting guidelines, relying on its cutting-edge AI and big data technology, to standardize medication services and drug information in the region, and to ensure medication safety through pre-positioning prescription vetting work.

JD Health released Yaojingtong, an omni-channel digitalization management platform for offline retail pharmacies, allowing offline retail pharmacies to directly connect with targeted upstream suppliers. Additionally, the platform offers various value-added services to offline retail pharmacies by comprehensively covering offline scenarios in order to improve the operational efficiency of pharmacies.

“By leveraging AI, big data and supply chain, we hope to further integrate technology into the healthcare industry to make it possible for people to access more medical resources at lower costs,” said Dongyuan Wang, the general manager of JD Health’s Intelligent Medical Services Department. “We are endeavoring to apply technology to provide high-quality pharmaceutical and healthcare products and professional healthcare services to people.”